Table 2.

Public Health Results in a 50-year-old single-year cohort over their remaining lifetimes

Assuming PPSV23 is NOT effective vs. non-bacteremic pneumonia	IPD cases	IPD deaths	NBP cases	NBP deaths
Black Population (cohort size = 549,197)
No vaccination	7,617	904	67,258	1,097
High-risk, immunocompromised get PPSV23	7,523	894	67,198	1,097
Present recs, (high-risk get PPSV23, immunocompromised get PCV13/PPSV23)	7,512	893	67,169	1,095
High-risk, immunocompromised get PCV13/PPSV23	7,512	893	66,985	1,092
All get PPSV23	7,484	890	67,199	1,097
All get PCV13/PPSV23	7,469	889	66,755	1,089
General Population (cohort size = 4,034,327)
No vaccination	32,635	3,792	420,634	8,593
High-risk, immunocompromised get PPSV23	32,163	3,745	420,401	8,600
Present recs, (high-risk get PPSV23, immunocompromised get PCV13/PPSV23)	32,110	3,739	420,260	8,590
High-risk, immunocompromised get PCV13/PPSV23	32,104	3,739	419,306	8,558
All get PPSV23	31,975	3,726	420,406	8,600
All get PCV13/PPSV23	31,897	3,718	417,829	8,540
Assuming PPSV23 IS effective vs. non-bacteremic pneumonia	IPD cases	IPD deaths	NBP cases	NBP deaths
Black Population (cohort size = 549,197)
No vaccination	7,618	904	67,109	1,087
High-risk, immunocompromised get PPSV23	7,524	894	66,664	1,078
Present recs, (high-risk get PPSV23,	7,512	893	66,636	1,076
immunocompromised get PCV13/PPSV23)
High-risk, immunocompromised get PCV13/PPSV23	7,512	893	66,589	1,075
All get PPSV23	7,485	890	66,333	1,073
All get PCV13/PPSV23	7,469	889	66,149	1,070
General Population (cohort size = 4,034,327)
No vaccination	32,636	3,792	419,602	8,506
High-risk, immunocompromised get PPSV23	32,165	3,745	417,512	8,443
Present recs, (high-risk get PPSV23,	32,112	3,740	417,371	8,433
immunocompromised get PCV13/PPSV23) High-risk, immunocompromised get PCV13/PPSV23	32,105	3,739	41 7,095	8,425
All get PPSV23	31,977	3,726	415,534	8,418
All get PCV13/PPSV23	31,898	3,718	414,360	8,390